The ECOG-ACRIN Cancer Research Group is a multi-disciplinary organization comprising nearly 1300 academic and community-based cancer centers and hospitals. It focuses on designing and conducting rigorous clinical trials aimed at improving treatment and outcomes for cancer patients.
2012
46-0745339
$17.59 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

Participating in innovative precision medicine trials to enhance cancer treatment.

Access a library of training videos for better engagement in cancer research.

Aiming to individualize breast cancer screening strategies through research.
Active Clinical Trials
Currently managing numerous clinical trials for cancer research.
Participating Institutions
A vast network of institutions contributing to cancer research.
International Collaborations
Engaging with international sites to expand research impact.
Conducts research aimed at evaluating new therapies for cancer treatment.
Learn MoreFocus on the development and application of biomarkers in cancer research.
Learn MoreStudies aimed at understanding and optimizing cancer care delivery.
Learn MoreOverall Score
65
48
/100
Program Expense Ratio
87.81%
20
/20
Program Revenue Growth
47.27%
18
/20
Leverage Ratio
0.6419
6
/20
Working Capital Ratio
0.1326
2
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 42.82M | 89.93% |
| Program Services | 4.793M | 10.07% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 1.463K | 0.00% |
| Total Revenue | 47.61M | 100.00% |
Health Associations
Health Research InstitutionHealth Associations
Health Research InstitutionHealth Associations
Health Research InstitutionHealth Associations
Health Research InstitutionHealth Associations
Health Research Institution